Human macrophages limit oxidation products in low density lipoprotein
AUTOR(ES)
Hultén, Lillemor Mattsson
FONTE
BioMed Central
RESUMO
This study tested the hypothesis that human macrophages have the ability to modify oxidation products in LDL and oxidized LDL (oxLDL) via a cellular antioxidant defence system. While many studies have focused on macrophage LDL oxidation in atherosclerosis development, less attention has been given to the cellular antioxidant capacity of these cells.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=555960Documentos Relacionados
- Human suction blister interstitial fluid prevents metal ion-dependent oxidation of low density lipoprotein by macrophages and in cell-free systems.
- PPARδ is a very low-density lipoprotein sensor in macrophages
- Role of endogenous ceruloplasmin in low density lipoprotein oxidation by human U937 monocytic cells.
- Low-density lipoprotein oxidation and the pathogenesis of atherosclerosis.
- Low density lipoprotein receptor activity in human monocyte-derived macrophages and its relation to atheromatous lesions.
